Cns Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.29

+0.01 (+0.23%)

As of Jun 23, 10:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +894.4% upside

Low Target $27.73

Average Target $42.66

High Target $55.88

Current Price $4.29

Current
$4.29

Target
$42.66

$27.73 $42.66 avg $55.88

Scenario Analysis

Bear Case

$27.73

546.4%

Low target

Base Case

$42.66

+894.4%

Avg target

Bull Case

$55.88

+1,202.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$12.36

-65.3% from high

52-Week Low

$1.90

+125.8% from low

Target vs 52W High

$42.66

+245.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.2%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+25.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+33.2%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+37.1%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+173.1%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%